HCA Holdings (HCA) Misses Q1 EPS by 2c, Maintains FY17 Guidance

HCA Holdings (NYSE: HCA) reported Q1 EPS of $1.74, $0.02 worse than the analyst estimate of $1.76. Revenue for the quarter came in at $10.6 billion versus the consensus estimate of $10.76 billion.

2017 Guidance

The 2017 guidance ranges for the year remain unchanged from our fourth quarter release and are as follows:

The Company’s 2017 guidance contains a number of assumptions, including:

• 2017 guidance includes full-year earnings for the Company’s Oklahoma facilities which are under agreement to be sold. The Company cannot at this time estimate a closing date.

• 2017 guidance excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claim costs and impairments of long-lived assets.

• 2017 guidance for EPS (diluted) includes an estimated $150 million income tax benefit, or $0.40 per diluted share, related to the accounting standard adopted during 2016 which requires the recording of excess tax benefits related to employee equity award settlements as a component of the provision for income taxes. The timing and amounts related to employee equity award settlements are difficult to project and may vary from this estimate.

Adjusted EBITDA is a non-GAAP financial measure. A table reconciling net income attributable to HCA Holdings, Inc. to Adjusted EBITDA is included in this release.

The Company’s guidance is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company’s “Forward-Looking Statements.”

For earnings history and earnings-related data on HCA Holdings (HCA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• HCA Healthcare Inc (HCA) PT Lowered to $431 at TD Cowen
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins